PHAT
#2559
Phathom Pharmaceuticals, Inc. - Common Stock
10.9 2 USD
-0.13%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-13.40%
Variación mensual
+5.81%
Variación en los últimos 6 meses
-27.44%
Cambio anual
+20.80%
Cierres anteriores
12.6 1
Open
10.9 2
Mínimo
10.9 2
High
10.9 2
Volumen
96
Financials
- Market Capitalization 870.94 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.32
Relación precio/flujo de caja
4.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2535 |  GERN Geron Corporation - Common Stock | 1.42 USD | -5.33% | -1.39% | +22.41% | +6.77% | 910.96 M USD | ||
| 2558 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.90 USD | -0.18% | -0.59% | +1.75% | +17.77% | 871.25 M USD | ||
| 2561 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.86 USD | -8.76% | -7.41% | +24.98% | +248.24% | 865.65 M USD | ||
| 2588 |  REPL Replimune Group, Inc. - Common Stock | 9.94 USD | -9.55% | -14.38% | +12.83% | -13.34% | 834.41 M USD |